AstraZeneca
AZN
AZN
502 hedge funds and large institutions have $13.4B invested in AstraZeneca in 2017 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 173 increasing their positions, 109 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $12.7B → $13.4B (+$651M)
0.78% more ownership
Funds ownership: 29.63% → 30.41% (+0.78%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
502
Holding in Top 10
6
Calls
$188M
Puts
$129M
Top Buyers
| 1 | +$146M | |
| 2 | +$86.9M | |
| 3 | +$79.5M | |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$59.2M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$38.3M |
Top Sellers
| 1 | -$109M | |
| 2 | -$97.4M | |
| 3 | -$40.4M | |
| 4 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$34.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$26.4M |